Dorothee von Laer

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Topics

Coronavirus Disease

Radical Prostatectomy

Saccharomyces Cerevisiae

Top Venues

Nature communications

Science advances

International journal of cancer

British journal of sports medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Christina Nnabuife, Fiona L Kearns, Chengjin Ye, Sofia N Moraes, Francesco Costacurta, Morgan A Esler, Hideki Aihara, Dorothee von Laer, Luis Martinez-Sobrido, Timothy G Palzkill, Rommie Elizabeth Amaro, Reuben Stewart Harris
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Science advances 9 (13) (2023)
Francesco Costacurta, Andrea Dodaro, David Bante, Helge Schoeppe, Bernhard Sprenger, Seyed Arad Moghadasi, Jakob Fleischmann, Matteo Pavan, Davide Bassani, Silvia Menin, Stefanie Rauch, Laura Krismer, Anna Sauerwein, Anne Heberle, Toni Rabensteiner, Joses Wei Hao Ho, Reuben Stewart Harris, Eduard Stefan, Rainer Schneider, Teresa Kaserer, Stefano Moro, Dorothee von Laer, Emmanuel Heilmann
A comprehensive study of SARS-CoV-2 main protease (M pro ) inhibitor-resistant mutants selected in a VSV-based system. bioRxiv : the preprint server for biology (2023)
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Christina Nnabuife, Fiona L Kearns, Chengjin Ye, Sofia N Moraes, Francesco Costacurta, Morgan A Esler, Hideki Aihara, Dorothee von Laer, Luis Martinez-Sobrido, Timothy G Palzkill, Rommie Elizabeth Amaro, Reuben Stewart Harris
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Science advances 9 (13) (2023)
Annika Rössler, Antonia Netzl, Ludwig Knabl, David Bante, Samuel H Wilks, Wegene Borena, Dorothee von Laer, Derek J Smith, Janine Kimpel
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography. Nature communications 14 (1) (2023)
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Christina Nnabuife, Fiona L Kearns, Chengjin Ye, Sofia N Moraes, Francesco Costacurta, Morgan A Esler, Hideki Aihara, Dorothee von Laer, Luis Martinez-Sobrido, Timothy G Palzkill, Rommie Elizabeth Amaro, Reuben Stewart Harris
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Science advances 9 (13) (2023)
Michaela Lackner, Annika Rössler, André Volland, Marlena Nastassja Stadtmüller, Brigitte Müllauer, Zoltan Banki, Johannes Ströhle, Angela Luttick, Jennifer Fenner, Bettina Sarg, Leopold Kremser, Paul Tone, Heribert Stoiber, Dorothee von Laer, Thorsten Wolff, Carsten Schwarz, Markus Nagl
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro . Emerging microbes & infections 11 (1) (2022)
Annika Rössler, Antonia Netzl, Ludwig Knabl, Helena Schäfer, Samuel H Wilks, David Bante, Barbara Falkensammer, Wegene Borena, Dorothee von Laer, Derek J Smith, Janine Kimpel
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants. Nature communications 13 (1) (2022)
Annika Rössler, Antonia Netzl, Ludwig Knabl, Helena Schäfer, Samuel H Wilks, David Bante, Barbara Falkensammer, Wegene Borena, Dorothee von Laer, Derek J Smith, Janine Kimpel
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants. Nature communications 13 (1) (2022)
Emmanuel Heilmann, Francesco Costacurta, Stephan Geley, Seyad Arad Mogadashi, Andre Volland, Bernhard Rupp, Reuben Stewart Harris, Dorothee von Laer
A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition. Communications biology 5 (1) (2022)
Jörg Paetzold, Janine Kimpel, Katie Bates, Michael Hummer, Florian Krammer, Dorothee von Laer, Hannes Winner
Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot. Nature communications 13 (1) (2022)
Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, André Volland, Claudia Ascher, Alexander Kurt Hermann Weiss, David Bante, Reuben Stewart Harris, Stefano Moro, Bernhard Rupp, Luis Martinez-Sobrido, Dorothee von Laer
SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Science translational medicine (2022)
Annika Rössler, Antonia Netzl, Ludwig Knabl, Helena Schäfer, Samuel H Wilks, David Bante, Barbara Falkensammer, Wegene Borena, Dorothee von Laer, Derek J Smith, Janine Kimpel
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants. Nature communications 13 (1) (2022)
Annika Rössler, Antonia Netzl, Ludwig Knabl, Helena Schäfer, Samuel H Wilks, David Bante, Barbara Falkensammer, Wegene Borena, Dorothee von Laer, Derek J Smith, Janine Kimpel
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants. Nature communications 13 (1) (2022)
Annika Rössler, Janine Kimpel, Verena Fleischer, Silke Huber, Dorothee von Laer, Wegene Borena, Reinhard Würzner, null null
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity. The Journal of infectious diseases 226 (11) (2022)
André Volland, Michael Lohmüller, Emmanuel Heilmann, Janine Kimpel, Sebastian Herzog, Dorothee von Laer
Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants. PLoS pathogens 17 (10) (2021)
Ludwig Knabl, Tanmay Mitra, Janine Kimpel, Annika Rössler, André Volland, Andreas Walser, Hanno Ulmer, Lisa Pipperger, Sebastian C Binder, Lydia Riepler, Katie Bates, Arnab Bandyopadhyay, Marta Schips, Mrinalini Ranjan, Barbara Falkensammer, Wegene Borena, Michael Meyer Hermann, Dorothee von Laer
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl. Communications medicine 1 (1) (2021)
Krishna Das, Elodie Belnoue, Matteo Rossi, Tamara Hofer, Sarah Danklmaier, Tobias Nolden, Liesa-Marie Schreiber, Katharina Angerer, Janine Kimpel, Sandra Hoegler, Bart Spiesschaert, Lukas Kenner, Dorothee von Laer, Knut Elbers, Madiha Derouazi, Guido Wollmann
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity. Nature communications 12 (1) (2021)
Tim Meyer, Dietrich Mack, Katrin Donde, Oliver Harzer, Werner Krutsch, Annika Rössler, Janine Kimpel, Dorothee von Laer, Barbara C Gärtner
Successful return to professional men's football (soccer) competition after the COVID-19 shutdown: a cohort study in the German Bundesliga. British journal of sports medicine 55 (1) (2020)
Gaby Sroczynski, Eva Esteban, Andreas Widschwendter, Wilhelm Oberaigner, Wegene Borena, Dorothee von Laer, Monika Hackl, Gottfried Endel, Uwe Siebert
Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria. International journal of cancer 147 (4) (2020)
Iris Koske, Annika Rössler, Lisa Pipperger, Monika Petersson, Isabel Barnstorf, Janine Kimpel, Christoph H Tripp, Patrizia Stoitzner, Zoltan Banki, Dorothee von Laer
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment. International journal of cancer 145 (7) (2019)
Carles Urbiola, Frédéric R Santer, Monika Petersson, Gabri van der Pluijm, Wolfgang Horninger, Patrik Erlmann, Guido Wollmann, Janine Kimpel, Zoran Culig, Dorothee von Laer
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer. International journal of cancer 143 (7) (2018)